A recent study demonstrated that IGF2 LOI cancer stem cells (CSCs) were generally more prone to tumor formation and had higher levels of autophagy (CD133 with high expression and p62 with low expression) compared with maintenance of imprinting (MOI) cells in patients with CRC (46). The gene discussed is IGF2; the disease is cancer.